CBT Pharmaceuticals Secures $9,750,000 Series A Financing

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=2b73d05d-3874-496b-a365-9bef32296227
Date
8/31/2016
Company Name
CBT Pharmaceuticals
Mailing Address
3375 Scott Blvd. Santa Clara, CA 95054 USA
Company Description
CBT Pharmaceuticals is an emerging life sciences oncology company focused on developing innovative medicines targeting the growth and proliferation of cancer cells for which available treatments are inadequate.
Website
http://www.cbtpharma.com
Transaction Type
Venture Equity
Transaction Amount
$9,750,000
Transaction Round
Series A
Proceeds Purposes
This financing allows us to advance two of our four development programs into human clinical trials.
M&A Terms
Venture Investor
OrbiMed
Venture Investor
Undisclosed